These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 16451255)

  • 1. Intravitreal triamcinolone injection for chronic diffuse diabetic macular oedema.
    Avci R; Kaderli B; Akalp FD
    Clin Exp Ophthalmol; 2006; 34(1):27-32. PubMed ID: 16451255
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intravitreal cortisone injection for refractory diffuse diabetic macular edema.
    Er H; Yilmaz H
    Ophthalmologica; 2005; 219(6):394-400. PubMed ID: 16286802
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intravitreal triamcinolone injection for chronic diabetic macular oedema with severe hard exudates.
    Avci R; Kaderli B
    Graefes Arch Clin Exp Ophthalmol; 2006 Jan; 244(1):28-35. PubMed ID: 16034605
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intravitreal triamcinolone acetonide for diabetic diffuse macular edema: preliminary results of a prospective controlled trial.
    Massin P; Audren F; Haouchine B; Erginay A; Bergmann JF; Benosman R; Caulin C; Gaudric A
    Ophthalmology; 2004 Feb; 111(2):218-24; discussion 224-5. PubMed ID: 15019365
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intravitreal triamcinolone for refractory diabetic macular edema.
    Martidis A; Duker JS; Greenberg PB; Rogers AH; Puliafito CA; Reichel E; Baumal C
    Ophthalmology; 2002 May; 109(5):920-7. PubMed ID: 11986098
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Repeated intravitreal high-dosage injections of triamcinolone acetonide for diffuse diabetic macular edema.
    Jonas JB; Spandau UH; Kamppeter BA; Vossmerbaeumer U; Harder B; Sauder G
    Ophthalmology; 2006 May; 113(5):800-4. PubMed ID: 16530840
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intravitreal triamcinolone acetonide for diffuse diabetic macular oedema: 6-month results of a prospective controlled trial.
    Audren F; Erginay A; Haouchine B; Benosman R; Conrath J; Bergmann JF; Gaudric A; Massin P
    Acta Ophthalmol Scand; 2006 Oct; 84(5):624-30. PubMed ID: 16965492
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intravitreal triamcinolone acetonide for diabetic macular edema.
    Chieh JJ; Roth DB; Liu M; Belmont J; Nelson M; Regillo C; Martidis A
    Retina; 2005; 25(7):828-34. PubMed ID: 16205559
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intravitreal triamcinolone acetonide versus combined intravitreal bevacizumab and dexamethasone in diffuse diabetic macular oedema.
    Sheth S; Rush R; Natarajan S; Gillies M
    Clin Exp Ophthalmol; 2011; 39(7):673-81. PubMed ID: 22452685
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intravitreal triamcinolone improves vision in eyes with chronic diabetic macular oedema refractory to laser photocoagulation.
    Negi AK; Vernon SA; Lim CS; Owen-Armstrong K
    Eye (Lond); 2005 Jul; 19(7):747-51. PubMed ID: 15359268
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of intravitreal versus posterior sub-Tenon's capsule injection of triamcinolone acetonide for diffuse diabetic macular edema.
    Cardillo JA; Melo LA; Costa RA; Skaf M; Belfort R; Souza-Filho AA; Farah ME; Kuppermann BD
    Ophthalmology; 2005 Sep; 112(9):1557-63. PubMed ID: 16019075
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intravitreal injection of triamcinolone for diffuse diabetic macular edema.
    Jonas JB; Kreissig I; Söfker A; Degenring RF
    Arch Ophthalmol; 2003 Jan; 121(1):57-61. PubMed ID: 12523885
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Two-year results of intravitreal triamcinolone acetonide injection for the treatment of diabetic macular edema.
    Batioğlu F; Ozmert E; Parmak N; Celik S
    Int Ophthalmol; 2007 Oct; 27(5):299-306. PubMed ID: 17453151
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intravitreal triamcinolone as a primary therapy in diabetic macular oedema.
    Karacorlu M; Ozdemir H; Karacorlu S; Alacali N; Mudun B; Burumcek E
    Eye (Lond); 2005 Apr; 19(4):382-6. PubMed ID: 15309024
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prospective study of intravitreal triamcinolone acetonide versus bevacizumab for macular edema secondary to central retinal vein occlusion.
    Ding X; Li J; Hu X; Yu S; Pan J; Tang S
    Retina; 2011 May; 31(5):838-45. PubMed ID: 21293319
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Duration of the effect of intravitreal triamcinolone acetonide as treatment for diffuse diabetic macular edema.
    Jonas JB; Degenring RF; Kamppeter BA; Kreissig I; Akkoyun I
    Am J Ophthalmol; 2004 Jul; 138(1):158-60. PubMed ID: 15234306
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intravitreal triamcinolone for refractory diabetic macular edema: two-year results of a double-masked, placebo-controlled, randomized clinical trial.
    Gillies MC; Sutter FK; Simpson JM; Larsson J; Ali H; Zhu M
    Ophthalmology; 2006 Sep; 113(9):1533-8. PubMed ID: 16828501
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intravitreal triamcinolone acetonide as primary treatment for diffuse diabetic macular edema: a prospective noncomparative interventional case series.
    Nicolò M; Nasciuti F; Lai S; Ghiglione D; Borgia L; Calabria G
    Eur J Ophthalmol; 2006; 16(1):129-33. PubMed ID: 16496256
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Primary intravitreal triamcinolone acetonide for diabetic massive macular hard exudates.
    Khairallah M; Zeghidi H; Ladjimi A; Yahia SB; Attia S; Zaouali S; Messaoud R
    Retina; 2005; 25(7):835-9. PubMed ID: 16205560
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Intravitreal injection of crystalline triamcinolone acetonide in the treatment of diffuse diabetic macular oedema].
    Jonas JB; Degenring R
    Klin Monbl Augenheilkd; 2002 Jun; 219(6):429-32. PubMed ID: 12136438
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.